AP7491 250 mg
Pill imprint AP7491 250 mg has been identified as Cefaclor 250 mg.
Cefaclor is used in the treatment of upper respiratory tract infection; urinary tract infection; bladder infection; sinusitis; kidney infections (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy.
Cefaclor 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Cefaclor Images
- Imprint:
-
AP7491
250 mg - Strength:
- 250 mg
- Color:
- Turquoise & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apothecon Inc.
Advertisement
More Cefaclor resources
- Cefaclor (Wolters Kluwer)
- Cefaclor Capsules (Wolters Kluwer)
- Cefaclor Extended-Release Tablets (Wolters Kluwer)
- Cefaclor Suspension (Wolters Kluwer)
- cefaclor (Cerner Multum)
- Cefaclor (AHFS DI)
- Cefaclor Capsules (FDA)
- Cefaclor Extended Release Tablets (FDA)
- cefaclor (FDA)
- Cefaclor (Wolters Kluwer)
Search Again
